Northern Trust’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,684
Closed -$280K 4546
2025
Q3
$280K Sell
15,684
-48,729
-76% -$1.24M ﹤0.01% 3856
2025
Q2
$1.34M Buy
+64,413
New +$1.35M ﹤0.01% 3229
2024
Q4
Sell
-7,103
Closed -$478K 4489
2024
Q3
$478K Buy
+7,103
New +$167K ﹤0.01% 3591
2023
Q4
Sell
-5,315
Closed -$45.5K 4543
2023
Q3
$45.5K Sell
5,315
-4
-0.1% -$40 ﹤0.01% 4191
2023
Q2
$58.6K Sell
5,319
-20,173
-79% -$247K ﹤0.01% 4180
2023
Q1
$337K Sell
25,492
-1,056
-4% -$15.6K ﹤0.01% 3610
2022
Q4
$335K Sell
26,548
-1,196
-4% -$59.1K ﹤0.01% 3637
2022
Q3
$2.69M Buy
27,744
+3,341
+14% +$382K ﹤0.01% 2848
2022
Q2
$2.25M Buy
24,403
+4,486
+23% +$635K ﹤0.01% 2991
2022
Q1
$4.28M Sell
19,917
-718
-3% -$168K ﹤0.01% 2668
2021
Q4
$7.06M Buy
20,635
+12,681
+159% +$4.89M ﹤0.01% 2483
2021
Q3
$2.84M Sell
7,954
-1,449
-15% -$541K ﹤0.01% 3088
2021
Q2
$3.63M Buy
+9,403
New +$3.49M ﹤0.01% 3030

Other funds holding TIL

Northern Trust's TIL Position: Q4 2025 in Review

Northern Trust sold out of Instil Bio (TIL) in Q4 2025, closing a stake of 15,684 shares — an estimated $280K sold.

Northern Trust first reported a position in TIL in Q2 2021 and held it in 13 quarters. The position peaked at $7.06M in Q4 2021. 29 funds tracked by Wall St. Rank hold TIL as of Q4 2025.

  • Northern Trust reported no remaining Instil Bio position as of Q4 2025 after selling out during the quarter.
  • Northern Trust sold 15,684 Instil Bio shares in Q4 2025, an estimated $280K.
  • Northern Trust first reported a position in Instil Bio in Q2 2021 and held it in 13 quarters.
  • Northern Trust's Instil Bio position peaked at $7.06M in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Instil Bio as of Q4 2025.

Based on Northern Trust's 13F filing for Q4 2025, filed 17 Feb 2026.